TY  - JOUR
AU  - van der Veere, Pieter J
AU  - van Harten, Argonde C
AU  - van Maurik, Ingrid S
AU  - Teunissen, Charlotte E
AU  - Barkhof, Frederik
AU  - Vos, Stephanie J B
AU  - Froelich, Lutz
AU  - Kornhuber, Johannes
AU  - Wiltfang, Jens
AU  - Maier, Wolfgang
AU  - Peters, Oliver
AU  - Rüther, Eckart
AU  - Frisoni, Giovanni B
AU  - Spiru, Luiza
AU  - Freund-Levi, Yvonne
AU  - Wallin, Åsa K
AU  - Hampel, Harald
AU  - Tsolaki, Magda
AU  - Kłoszewska, Iwona
AU  - Mecocci, Patrizia
AU  - Vellas, Bruno
AU  - Lovestone, Simon
AU  - Galluzzi, Samantha
AU  - Herukka, Sanna-Kaisa
AU  - Santana, Isabel
AU  - Baldeiras, I.
AU  - de Mendonca, Alexandre
AU  - Silva, Dina
AU  - Chetelat, Gael
AU  - Poisnel, Géraldine
AU  - Visser, Pieter Jelle
AU  - Johnson, Sterling C
AU  - Stormrud, Erik
AU  - Hansson, Oskar
AU  - Palmqvist, Sebastian
AU  - Piñol-Ripoll, Gerard
AU  - Berkhof, Johannes
AU  - van der Flier, Wiesje M
TI  - Revising the ABIDE MCI to dementia prediction model for automated cerebrospinal fluid assays.
JO  - Alzheimer's and dementia
VL  - 22
IS  - 2
SN  - 1552-5260
CY  - Hoboken, NJ
PB  - Wiley
M1  - DZNE-2026-00180
SP  - e71192
PY  - 2026
AB  - Automated cerebrospinal fluid (CSF) biomarker assays have largely replaced manual immunoassays for measuring amyloid pathology in CSF. We refitted and validated the ABIDE model, predicting progression from mild cognitive impairment (MCI) to dementia, with CSF measurements from the automated Elecsys platform.We included 2413 MCI participants (998 [41
KW  - Humans
KW  - Cognitive Dysfunction: cerebrospinal fluid
KW  - Cognitive Dysfunction: diagnosis
KW  - Dementia: cerebrospinal fluid
KW  - Dementia: diagnosis
KW  - Male
KW  - Female
KW  - Aged
KW  - Disease Progression
KW  - Biomarkers: cerebrospinal fluid
KW  - Amyloid beta-Peptides: cerebrospinal fluid
KW  - Cohort Studies
KW  - Aged, 80 and over
KW  - Alzheimer's disease (Other)
KW  - automated cerebrospinal fluid assays (Other)
KW  - cerebrospinal fluid (Other)
KW  - dementia (Other)
KW  - mild cognitive dementia (Other)
KW  - prediction (Other)
KW  - Biomarkers (NLM Chemicals)
KW  - Amyloid beta-Peptides (NLM Chemicals)
LB  - PUB:(DE-HGF)16
C6  - pmid:41657128
DO  - DOI:10.1002/alz.71192
UR  - https://pub.dzne.de/record/285056
ER  -